The purpose of this study was to investigate the relationship between sodium nitroprusside-induced relaxation, inhibition of the sodium-potassium pump, and cyclic guanosine monophosphate. Exposure of rat thoracic aorta to ouabain, or potassium-or magnesium-free Krebs-Ringer bicarbonate solution, procedures which presumably inhibit the sodium-potassium pump, or to potassium chloride or tetraethylammonium, membrane-depolarizing agents, inhibited relaxation to nitroprusside. These conditions had little or no effect on the elevated cyclic guanosine monophosphate levels at a concentration of nitroprusside (0.1 J*M) that relaxed norepinephrine contracted tissues by 80%. However, at a maximum relaxant concentration of nitroprusside (1.0 MM), these conditions decreased the elevation of cyclic guanosine monophosphate. The inhibition of elevated cyclic guanosine monophosphate levels was independent of the endothelium, extracellular calcium, and the cyclic guanosine monophosphate phosphodiesterase inhibitor, M&B 22,948. The inhibitory effects of ouabain and of potassium-and magnesium-free solution on the increased levels of cyclic guanosine monophosphate caused by 1.0 MM nitroprusside were abolished when tissues were incubated without norepinephrine, or with norepinephrine in the presence of the a-adrenergic blocker, phentolamine. In contrast, a /3-adrenergic blocker, propranolol, had no effect on the ouabain-induced inhibition of elevated cyclic guanosine monophosphate levels, with norepinephrine present. These results are consistent with the hypothesis that membrane events regulate cyclic guanosine monophosphate synthesis. At nitroprusside concentrations greater than 0.1 fiM, the formation of cyclic guanosine monophosphate appears to be coupled to the status of the smooth muscle cell membrane and integrity of the sodium-potassium pump. Furthermore, the elevated cyclic guanosine monophosphate levels induced by nitroprusside may be compartmentalized and, depending upon the intracellular concentration, may be associated with several functions. These functions may include activation of the sodium-potassium pump and/or membrane hyperpolarization. However, an effect of cyclic guanosine monophosphate on sodiumpotassium pump activity and/or membrane potential remains to be demonstrated. (Circ Res 57: 164-170, 1985) 
IT has been hypothesized that sodium nitroprussideinduced relaxation of vascular smooth muscle may be mediated through activation of the sodium-potassium pump (Na + -K + pump) and/or membrane hyperpolarization (Rapoport and Murad, 1983a) . This hypothesis was based upon the observation that exposure of rat aorta to ouabain or potassiumfree (K + -free) Krebs-Ringer bicarbonate solution, conditions which inhibit the Na + -K + pump (Fleming, 1980) , inhibited relaxation to nitroprusside. Potassium-induced relaxation, which is due to Na + -K + pump activation (Webb and Bohr, 1978) , was potentiated by nitroprusside.
Another hypothesis to explain nitroprusside-induced smooth muscle relaxation involves the formation of cyclic guanosine monophosphate [cGMP (Katsuki and Murad, 1977; Katsuki et al., 1977a Katsuki et al., , 1977b Schultz et al., 1977) ]. Thus, it was suggested that cGMP may activate the Na + -K + pump, which then induces relaxation (Rapoport and Murad, 1983a) . This hypothesis was supported by the observations that relaxations induced by 8-bromo cGMP and the cGMP phosphodiesterase inhibitor, M&B 22,948 (Lugnier et al., 1983) , were inhibited by exposure to ouabain and K + -free Krebs-Ringer bicarbonate solution and potentiated by potassiuminduced relaxation (Rapoport and Murad, 1983a) . Furthermore, ouabain did not alter the nitroprusside-induced elevated levels of cGMP. The purpose of this study was to investigate this phenomenon further, using various agents and procedures known to inhibit the Na + -K + pump and/or cause membrane depolarization, and to examine their effects on relaxation and cGMP levels at several concentrations of nitroprusside.
Methods

Relaxation Studies
Thoracic aortas were removed from male Sprague-Dawley rats weighing 240-330 g and were cut into spiral strips (approximately 2 mm X 1 cm). The endothelium was removed from some strips, as previously described (Rapoport and Murad, 1983b) . The strips then were mounted in organ baths containing Krebs-Ringer bicarbonate solution at 37°C which was gassed with 95% O 2 -5% CO2 and which had the following composition (in nw): NaCl, 118.5; KC1, 4.74; MgSO 4 , 1.18; KH 2 PO 4 1.18; CaCl 2 2.5; NaHCO 3 , 24.9; glucose, 10. Resting tension of 0.2-g force was maintained throughout the experiment. Tension was readjusted whenever it went below 0.2-g force, which sometimes occurred after washout of the contractile agent. Tissues were allowed to equilibrate for 2 hours before the experiments were begun.
Some aortas then were exposed to either Krebs-Ringer bicarbonate solution prepared without KG or KH2PO4 (K + -free) or without MgSO 4 (Mg^-free) for 30 minutes, to 1 mM ouabain for 15 minutes, or to 1 mM tetraethylammonium, 1 MM phentolamine, or 1 MM propranolol for 30 minutes. Substitution of NaCl and NaH 2 PO 4 for KCI and KH 2 PO 4 , respectively, in K + -free solution did not alter the inhibition of sodium nitroprusside-induced relaxation (data not shown). Inhibition of relaxation to nitroprusside was also unaffected when 1.18 mM NaCl was added to Mg ++ -free solution, or when Mg ++ -free solution was prepared which contained 1.6 mM CaCl 2 rather than 2.5 mM CaCU (data not shown). We performed the latter experiment to determine whether possible increased Ca ++ activity due to removal of SO 4 " may have influenced the results. Tissues then were contracted with 0.3 MM norepinephrine or 40 mM KCI, and sodium nitroprusside or isoproterenol was added at the concentrations indicated. Results are expressed as percent relaxation of the contraction due to norepinephrine or KCI.
cGMP Measurements
Strips with or without endothelium were incubated at 37°C in flasks containing Krebs-Ringer bicarbonate solution which was continuously gassed with 95% O 2 -5% CO 2 . Next, tissues were pretreated with ouabain, tetraethylammonium, phentolamine, or propranolol, or were exposed to K + -free or Mg ++ -free Krebs-Ringer bicarbonate solution, as described above. Additional tissues were exposed to Ca ++ -free solution containing 2 mM EGTA or to the cGMP phosphodiesterase inhibitor, M&B 22,948 (0.1 ITIM), for 36 minutes. The tissues then were allowed to rest or were exposed to 0.3 MM norepinephrine for 6 or 8 minutes, or to KCI for 8 minutes (plateau contraction), followed by nitroprusside for 2 minutes [maximum level of cGMP accumulation (Rapoport et al., 1983) ]. Tissues then were frozen between clamps precooled in liquid nitrogen, and cGMP levels were assayed as described previously (Katsuki and Murad, 1977) . Frozen tissues were homogenized in 6% trichloroacetic acid, and samples were centrifuged. Supernatant fractions were extracted with ether, and a portion of the extract was acetylated (Harper and Brooker, 1975) and radioimmunoassayed for cGMP (Steiner et al., 1972; Kimura et al., 1974) . Protein was 165 determined by the method of Lowry et al. (1951) , using bovine serum albumin as standard. Results are expressed as means ± SE. Significance was accepted at the 0.05 level of probability, determined by Student's paired or unpaired Mest, as indicated.
Materials
Sodium nitroprusside (referred to as "nihoprusside'), lnorepinephrine hydrochloride, d, /-propranolol hydrochloride, (Z)-isoproterenol hydrochloride, and ouabain octahydrate were obtained from Sigma, and tetraethylammonium chloride (referred to as "tetraethylammonium') was from Eastman Kodak. M&B 22,948 was a gift from May and Baker Ltd., Dagenham, Essex; UK and Regitine (phentolamine)-hydrochloride was a gift of Ciba-Geigy Corp., Summit, N.J. Other materials were obtained as previously described (Katsuki and Murad, 1977; Mittal and Murad, 1977) .
Results
Effect of Na + -K + Pump Inhibition and Membrane Depolarization on Nitroprus9ide-Induced Elevated Levels of cGMP
Exposure of aorta to KCI, norepinephrine plus tetraethylammonium, norepinephrine in K + -free or Mg ++ -free Krebs-Ringer bicarbonate solution, or norepinephrine plus ouabain inhibited increased levels of cGMP due to 1.0 MM nitroprusside (Table  1) . Exposure to norepinephrine tended to decrease the nitroprusside-induced elevated cGMP levels, although this difference was not significant. In contrast, the inhibitory effects on the elevated cGMP levels due to 0.1 HM nitroprusside were of much smaller magnitude, or were absent. The magnitude of inhibition of cGMP levels due to the above procedures was not significantly different in tissues with or without endothelium (some data not shown). Exposure to K + -free or Mg ++ -free Krebs-Ringer bicarbonate solution tended to decrease basal cGMP levels; however, these differences were relatively small and were not consistent. Removal of the endothelium lowered basal levels of cGMP and had no effect on nitroprusside-induced elevated cGMP levels, as has been previously shown (Rapoport and Murad, 1983a) .
Effect of KCI, Tetraethylammonium, and Mg ++ -free Solution on Nitroprusside-induced Relaxation
Nitroprusside-induced relaxation was previously shown to be inhibited by exposure to ouabain or K + -free Krebs-Ringer bicarbonate solution (Rapoport and Murad, 1983a) . Aortas contracted with 40 mM KCI were also significantly less sensitive to relaxation by nitroprusside than those contracted with 0.3 HM norepinephrine ( Fig. 1) . Nitroprusside produced half-maximal relaxation at about 0.03 HM with norepinephrine and about 0.07 HM with KCI. The maximum relaxation to nitroprusside was inhibited by exposure to 40 mM KCI. Contractions induced by 0.3 MM norepinephrine were not signifi- Rat aortas with or without endothelium were incubated without or with 1 mM tetraethylammonium (TEA) or K + -free or Mg^-free Krebs-Ringer bicarbonate solution for 30 minutes or 1 mM ouabain for 15 minutes. Tissues were then contracted with 0.3 MM norepinephrine for 6 minutes, followed by 0.1 or 1.0 MM nitroprusside (SNP) for 2 minutes. In the expenments with 40 mM KCl and 0.3 MM norepinephrine, tissues were contracted for 8 minutes (see Methods). cGMP levels then were assayed, as described in Methods. Data derived from eight separate experiments are shown. Four conditions were tested in each experiment. Each condition was tested on a quarter-segment of aorta obtained from the same vessel, n = the number of aortas and, thus, the number of repetitions of each experimental condition. Results are expressed as means ± SE.
• Significantly less than tissues unexposed to nitroprusside. f Significantly greater than tissues unexposed to nitroprusside. t Significantly less than tissues exposed to nitroprusside. § Significantly less than tissues exposed to nitroprusside, using paired but not unpaired /-test.
cantly different from those induced by 40 mM KCl (0.69 ± 0.03 and 0.64 ± 0.04-g force, respectively; mean ± SE, n = 6 in each case). Removal of the endothelium had no effect on the inhibition of nitroprusside-induced relaxation caused by KCl or ouabain (data not shown). Exposure of tissues to Mg ++ -free Krebs-Ringer bicarbonate solution also significantly inhibited relaxations to nitroprusside (Fig. 2) . Half-maximal re- laxations occurred at approximately 0.04 ^M and 0.09 n\i nitroprusside in normal and Mg^-free solution, respectively. Maximum relaxation to nitroprusside was also slightly but significantly reduced in Mg^-free solution. Removal of extracellular Mg" 1 " 1 " did not significantly alter contractile responses to 0.3 / XM norepinephrine, which were 0.86 ± 0.05 and 0.86 ± 0.05-g force in the absence and presence of Mg ++ , respectively. Rapapori et a/./Na*-K + Pump, Relaxation, and cGMP Tetraethylammonium (1 ITIM) significantly decreased control relaxations to 0.1 HM nitroprusside from 77.7 ± 7.0 to 59.0 ± 7.7% of the contraction induced by 0.3 ^M norepinephrine (mean ± SE, n = 6 in each case), and to 1.0 MM nitroprusside from 88.5 ± 2.9 to 63.2 ± 5.8% (mean ± SE, n = 5 in each case). Contractions elicited by 0.3 J*M norepinephrine in the presence and absence of tetraethylammonium were 0.84 ± 0.06 and 0.78 ± 0.06-g force, respectively (mean ± SE, n = 10 in each case), and were not significantly different.
Effect of Norepinephrine on Ouabain-and K +and Mg^-Free Solution-Induced Inhibition of Nitroprus9ide-Elevated cGMP Levels
The ability of ouabain, K + -free, or Mg ++ -free Krebs-Ringer bicarbonate solution to inhibit increased cGMP levels caused by 1.0 MM nitroprusside was enhanced by the presence of 0.3 MM norepinephrine (Table 2) . Ouabain had no effect on increased cGMP levels induced by nitroprusside in the absence of norepinephrine, whereas the magnitude of inhibition due to K + -free or Mg ++ -free solution was reduced in the absence of norepinephrine. Exposure to norepinephrine tended to decrease the effect of nitroprusside on levels of cGMP, although this difference was not always significant (see Tables  1 and 2) .
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Effect of Propranolol and Phentolamine on Ouabain-Induced Inhibition of Nitroprusside-Elevated cGMP Levels in the Presence of Norepinephrine
The inhibition of nitroprusside-induced increased cGMP levels by ouabain in the presence of norepinephrine was unaffected by 1 MM propranolol, but was completely abolished by prior exposure to 1 MM phentolamine (Table 3) . Propranolol did not alter contraction to 0.3 MM norepinephrine. However, relaxations induced by a maximally effective concentration of isoproterenol (3.0 MM) were significantly reduced by 1 MM propranolol from 67.2 ± 8.0 to 5.6 ± 1.3% of the contraction to 0.3 MM norepinephrine, respectively (mean ± SE, n = 3 in each case). Phentolamine (1 MM) significantly decreased contractions to 0.3 / XM norepinephrine by 89.4%. Propranolol and phentolamine had no effect on basal levels of cGMP (data not shown).
Effect of Extracellular Ca ++ Depletion and Phosphodiesterase Inhibition on K + -Free Solution-Induced Inhibition of Nitroprusside-Elevated cGMP Levels
Removal of extracellular Ca" 1 " 1 " in the presence of EGTA (2 mM) had no effect on the K + -free solutioninduced inhibition of the elevated cGMP levels caused by nitroprusside (Table 4 ). Nitroprusside- Rat aortas were allowed to rest or were exposed to 1 ITIM ouabain for 15 minutes. Some tissues then were contracted with 0.3 /IM norepinephrine, followed by 1 /IM nitroprusside for 2 minutes. cGMP levels then were assayed as described in Methods. Four conditions were tested in each experiment, and the effects of these conditions were tested on four segments derived from the same aorta, n = 4, 6, and 8 in experiments 1, 2, and 3, respectively. Results are expressed as means ± SE. * Significantly less than tissues exposed to nitroprusside in the absence of norepinephrine or in the absence of ouabain, K + -free or Mg^-free solution.
t Significantly less than tissues exposed only to nitroprusside. Rat aortas were allowed to rest or were exposed to 1 ITIM ouabain for 15 minutes and/or 1 MM propranolol or 1 MM phentolamine for 30 minutes, followed by 0.3 M M norepinephrine for 6 minutes and then to 1 MM nitroprusside for 2 minutes. cGMP levels then were assayed as described in Methods. Four conditions were tested in each experiment, and the effects of these conditions were tested on four segments derived from the same aorta, n = 3 and 4 in experiments 1 and 2, respectively. Results are expressed as means ± SE. * Significantly less than tissues unexposed to ouabain or to phentolamine.
induced increased levels of cGMP were independent of extracellular Ca ++ , as has been shown by others (Katsuki and Murad, 1977; Schultz et al., 1977) . Basal levels of cGMP were decreased by 63.3% when Ca ++ was removed (data not shown). Exposure of aorta to the cGMP phosphodiesterase Rat aortas were exposed to Ca ++ -free Krebs-Ringer bicarbonate solution in the presence of 2 n\M EGTA or to the phosphodiesterase inhibitor, M&B 22,948 (0.1 mM) for 36 minutes. Some tissues were exposed to K + -free solution for 36 minutes or were allowed to rest. Nitroprusside (1 MM) was then added, and cGMP levels were assayed as described in Methods. Four conditions were tested in each experiment, and the effects of these conditions were tested on four segments derived from the same aorta, u = 8 and 12 in experiments 1 and 2, respectively. Results are expressed as means ± SE. * Significantly less than tissues unexposed to K + -free solution using paired but not unpaired /-test.
f Significantly less than tissus unexposed to K + -free solution or to tissues exposed to M&B 22,948.
J Significantly greater than tissues unexposed to M&B 22,948.
inhibitor, M&B 22,948 (0.1 nun), also had no effect on the K + -free solution-induced inhibition of the elevated cGMP levels caused by nitroprusside (Table  4 ). M&B 22,948 potentiated the cGMP levels elevated by nitroprusside. Basal levels of cGMP were increased 2.2-fold by M&B 22,948 (data not shown).
Discussion
The relationship between sodium nitroprussideinduced relaxation, Na + -K + pump inhibition, and cGMP levels is not known. The present data demonstrate that the inhibitory effects of the Na + -K + pump inhibitors and membrane-depolarizing agents on the elevated cGMP levels due to nitroprusside depend upon the concentration of nitroprusside. At a relatively low nitroprusside concentration (0.1 ^M), these agents and procedures were without effect, or only slightly inhibited the elevated cGMP levels (see also, Rapoport and Murad, 1983a) . In contrast, the elevated cGMP levels due to 1.0 MM nitroprusside were inhibited by these agents and procedures. These results suggest that cGMP may be compartmentalized within the smooth muscle cell.
The mechanism(s) by which the elevated cGMP levels due to 1.0 NU nitroprusside were inhibited by the Na + -K + pump inhibitors and membrane-depolarizing agents is not known. Whether the inhibition of the elevated cGMP levels is due to decreased Na + -K + pump activity and/or to the presumed effects of the decreased activity, such as membrane depolarization and intracellular Na + accumulation, is not clear. The inhibition does not appear to be due to the possible |8-adrenergic stimulatory effect of norepinephrine, since propranolol did not alter the inhibition. The decreased accumulation of cGMP appears to be due to decreased formation of cGMP, as opposed to increased hydrolysis, since exposure to a relatively specific cGMP phosphodiesterase in- hibitor, M&B 22,948 (Lugnier et al., 1983) , did not alter the magnitude of inhibition. Whether the inhibition of cGMP synthesis is due to decreased feedback stimulation of guanylate cyclase or to a more direct pathway which results in less guanylate cyclase activation, is not known, but the inhibition appears to be independent of extracellular Ca ++ and the presence of the endothelium. Furthermore, the inhibition of cGMP synthesis is not restricted to nitroprusside-induced elevated cGMP levels, since similar results were observed with elevated cGMP levels induced by the endothelium-dependent vasodilator, acetylcholine (unpublished observation).
The ouabain-induced inhibition of the elevated cGMP levels caused by nitroprusside was abolished in the absence of norepinephrine, and the inhibition induced by K + -free or Mg ++ -free solutions was reduced. Whether the inhibition of nitroprusside-induced elevated cGMP levels by K + -free or Mg ++free solution in the absence of norepinephrine is due to the same mechanism responsible for the inhibition observed in the presence of norepinephrine remains to be investigated.
The mechanism by which norepinephrine apparently unmasks the inhibitory effect of the Na -K + pump antagonists, or vice versa, on nitroprussideinduced cGMP synthesis, is not known. Blockade of the a-adrenergic receptor by phentolamine, which inhibited the norepinephrine-induced contraction, also prevented the inhibitory effects of ouabain in the presence of norepinephrine. Whether the effect of phentolamine is due to antagonism at the level of the a-adrenergic receptor or at a step following receptor activation, such as contraction, remains to be investigated. Since the inhibitory effects of the Na + -K + pump antagonists in the presence of norepinephrine on nitroprusside-induced relaxation and elevated cGMP levels were similar to those induced by KC1 and terraethylammonium, these two classes of agents may share a common inhibitory mechanism. In any case, the inhibition suggests a novel, complex interaction between nitroprusside, norepinephrine, the Na + +-K pump, and/or the effects of Na-K pump inhibition, such as membrane depolarization and accumulation of intracellular Na, by which cGMP synthesis and relaxation may be regulated.
An apparent dissociation between cGMP levels and relaxation was observed, in that the inhibition of relaxation to 1.0 fiM nitroprusside by ouabain, KC1, terraethylammonium, or K + -free solution in the presence of norepinephrine was accompanied by greater elevations in cGMP levels than with 0.1 ^M nitroprusside, whereas 0.1 fiM nitroprusside caused greater relaxation (see also Rapoport and Murad, 1983a) . The reason for this is not clear. However, it may be that the association of cGMP with relaxation is due to the rate of change of cGMP accumulation, rather than to the absolute or new steady state levels of the nucleotide.
It is of interest to note that the effects of norepinephrine and KG to decrease the elevated cGMP 169 levels due to nitroprusside were dependent upon the nitroprusside concentration. It may be reasonable to suggest that the magnitude of inhibition will vary depending upon the tissue under investigation, its particular response to the contractile agent, and the concentration of nitrovasodilator.
These results, and those of our previous study (Rapoport and Murad, 1983a) , demonstrate that agents and procedures which inhibit the Na + -K + pump inhibit nitroprusside-induced relaxation. Exposure to the membrane-depolarizing agents, KG (Somlyo and Somlyo, 1968 ) and terraethylammonium (Bolton, 1979) , also inhibited relaxation to nitroprusside. Others have also shown an inhibition of nitroprusside-induced relaxation in arteries contracted with KG (Kreye et al., 1975; Verhaege and Shephard, 1976; Hester et al., 1979 , Karaki et al., 1980 Lincoln, 1983) . Terraethylammonium and KG only slightly depressed the elevated cGMP levels caused by 0.1 /XM nitroprusside. Thus, it may be that the membrane depolarization which presumably results from inhibition of the Na + -K + pump (Fleming, 1980) is in some manner responsible for inhibition of the relaxation.
It is difficult to discern the relationship between cGMP levels, Na + -K + pump activity, and relaxation. The agents and procedures that presumably inhibit the Na + -K + pump and the membrane-depolarizing agents inhibited nitroprusside-induced relaxation, whereas they had little or no effect on the elevated cGMP levels due to a relatively low concentration (0.1 ^M) of nitroprusside. Thus, these agents and procedures may inhibit relaxation at a step following cGMP formation. OUT previous results, which demonstrate that relaxations to the cGMP phosphodiesterase inhibitor, M&B 22,948, and to 8-bromo cGMP, were inhibited by Na + -K + pump inhibitors (Rapoport and Murad, 1983a) , support this hypothesis.
The indirect nature of the present evidence makes it difficult to formulate a conclusion regarding the mechanism by which the Na + -K + pump inhibitors prevent nitroprusside-induced relaxation. One might speculate that the elevated cGMP levels interact at one or more of the steps which follow Na + -K + pump inhibition, such as increased intracellular Na concentration and membrane depolarization. Indeed, terraethylammonium and KG, which, under the present conditions, presumably induce membrane depolarization, inhibited relaxation. However, the possibility that cGMP increases Na + -K + pump activity must also be considered. Possible effects of cGMP and the steps which appear to follow cGMP formation, such as activation of cGMP-dependent protein kinase (Fiscus et al., 1984) and protein phosphorylation (Rapoport et al., 1982; 1983; Rapoport and Murad, 1983c) , on these processes, await further investigation.
The inhibitory effects of the Na + -K + pump inhibitors and membrane-depolarizing agents on nitroprusside-induced relaxation may be due to an additional mechanism at high nitroprusside concentra-tions, that of decreased cGMP formation. Thus, it appears that cGMP synthesis is regulated by an additional, and as yet unknown, mechanism. Whereas there is a complex interaction for the regulation of cGMP synthesis and relaxation, the inhibitory effects observed require the activity of the Na + -K + pump and the a-adrenergic receptor. This mechanism could be decreased feedback stimulation of guanylate cyclase or a more direct inhibition of the enzyme. The higher levels of cGMP with greater concentrations of nitroprusside may also represent different compartments within the smooth muscle cell. Perhaps the different pools of cGMP have different functions in addition to relaxation, and relaxation may be induced through several cGMPdependent mechanisms.
